Drayson Health: Professor David Clifton joins Drayson Health as Research Director
Apr 03, 2018 11:01 am UTC| Business
NEWS RELEASE Professor David Clifton joins Drayson Health as Research Director World-leading expert on the application of artificial intelligence to healthcare brings IP and applied clinical research experience...
ZED Network Announces Advisory Board
Apr 03, 2018 11:00 am UTC| Business
TORONTO, April 03, 2018 -- Integrated global payments platform ZED Network today announced its advisory board, with leaders in finance and blockchain joining ZED’s mission to create a blockchain-powered internetwork of...
Apr 03, 2018 11:00 am UTC| Business
NEW YORK and DENVER, April 03, 2018 -- BNP Paribas Securities Services, a leading global custodian with over $11.3 trillion in assets under custody, and Janus Henderson Investors (NYSE:JHG) (ASX:JHG), today announced...
Apr 03, 2018 11:00 am UTC| Business
VANCOUVER, British Columbia, April 03, 2018 -- Chimata Gold Corp. (TSX.V:CAT) (“Chimata” or the “Company”) announces that it has commenced drilling at the Kamativi Lithium Tailings Project (the “Project”) in Zimbabwe....
BeyondSpring Provides Operational Update and Fourth-Quarter and Full-Year 2017 Financial Results
Apr 03, 2018 11:00 am UTC| Business
NEW YORK, April 03, 2018 -- BeyondSpring Inc. (the “Company”) (NASDAQ:BYSI), a global, clinical-stage biopharmaceutical company focused on the development of transformative cancer therapies, today announced its...
Leading Molecular Diagnostics Executive Ronnie Andrews Appointed to OncoCyte’s Board of Directors
Apr 03, 2018 11:00 am UTC| Business
ALAMEDA, Calif., April 03, 2018 -- OncoCyte Corporation (NYSE American:OCX) today announced the appointment of Ronald Andrews, Jr., an executive with over 30 years’ experience in the molecular diagnostics and genomics...
BeiGene Appoints J. Samuel Su to its Board of Directors
Apr 03, 2018 11:00 am UTC| Business
BEIJING, China and CAMBRIDGE, Mass., April 03, 2018 -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and...